News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
204,529 Results
Type
Article (15630)
Company Profile (29)
Press Release (188870)
Multimedia
Podcasts (185)
Webinars (6)
Section
Business (69673)
Career Advice (1642)
Deals (9719)
Drug Delivery (103)
Drug Development (33083)
Employer Resources (80)
FDA (5173)
Job Trends (4773)
News (115285)
Policy (8480)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (975)
Accelerated approval (13)
Adcomms (25)
Allergies (58)
Alliances (11748)
ALS (82)
Alzheimer's disease (626)
Antibody-drug conjugate (ADC) (204)
Approvals (5198)
Artificial intelligence (207)
Autoimmune disease (66)
Automation (11)
Bankruptcy (92)
Best Places to Work (3948)
BIOSECURE Act (11)
Biosimilars (78)
Biotechnology (23)
Bladder cancer (72)
Brain cancer (31)
Breast cancer (299)
Cancer (2023)
Cardiovascular disease (168)
Career advice (1353)
Career pathing (36)
CAR-T (157)
CDC (33)
Celiac Disease (1)
Cell therapy (412)
Cervical cancer (11)
Clinical research (28020)
Collaboration (492)
Company closure (3)
Compensation (103)
Complete response letters (29)
COVID-19 (1235)
CRISPR (52)
C-suite (782)
Cystic fibrosis (55)
Data (2292)
Decentralized trials (1)
Denatured (66)
Depression (70)
Diabetes (179)
Diagnostics (2133)
Digital health (8)
Diversity (8)
Diversity, equity & inclusion (23)
Drug discovery (90)
Drug pricing (109)
Drug shortages (15)
Duchenne muscular dystrophy (98)
Earnings (19657)
Editorial (45)
Employer branding (8)
Employer resources (80)
Events (22502)
Executive appointments (894)
FDA (6310)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (557)
Gene editing (109)
Generative AI (18)
Gene therapy (310)
GLP-1 (525)
Government (1736)
Grass and pollen (1)
Guidances (173)
Healthcare (6334)
HIV (21)
Huntington's disease (30)
IgA nephropathy (34)
Immunology and inflammation (150)
Immuno-oncology (30)
Indications (30)
Infectious disease (1342)
Inflammatory bowel disease (68)
Inflation Reduction Act (12)
Influenza (36)
Intellectual property (63)
Interviews (336)
IPO (4366)
IRA (32)
Job creations (858)
Job search strategy (1090)
JPM (57)
Kidney cancer (8)
Labor market (57)
Layoffs (297)
Leadership (34)
Legal (1343)
Liver cancer (35)
Longevity (8)
Lung cancer (316)
Lymphoma (181)
Machine learning (14)
Management (30)
Manufacturing (286)
MASH (73)
Medical device (5011)
Medtech (5030)
Mergers & acquisitions (5776)
Metabolic disorders (581)
Multiple sclerosis (65)
NASH (18)
Neurodegenerative disease (148)
Neuropsychiatric disorders (41)
Neuroscience (1177)
Neurotech (1)
NextGen: Class of 2026 (2266)
Non-profit (1595)
Now hiring (37)
Obesity (315)
Opinion (247)
Ovarian cancer (61)
Pain (57)
Pancreatic cancer (92)
Parkinson's disease (91)
Partnered (17)
Patents (118)
Patient recruitment (172)
Peanut (24)
People (37866)
Pharmaceutical (7)
Pharmacy benefit managers (6)
Phase 1 (12119)
Phase 2 (11877)
Phase 3 (7897)
Pipeline (1847)
Policy (194)
Postmarket research (601)
Preclinical (2824)
Press Release (12)
Prostate cancer (98)
Psychedelics (38)
Radiopharmaceuticals (127)
Rare diseases (377)
Real estate (1466)
Recruiting (36)
Regulatory (7037)
Reports (9)
Research institute (874)
Resumes & cover letters (278)
Rett syndrome (13)
RNA editing (13)
RSV (41)
Schizophrenia (75)
Series A (102)
Series B (70)
Sickle cell disease (47)
Special edition (18)
Spinal muscular atrophy (67)
Sponsored (15)
Startups (1241)
Stomach cancer (10)
Supply chain (31)
Tariffs (38)
The Weekly (117)
Vaccines (477)
Venture capital (54)
Weight loss (259)
Women's health (38)
Worklife (18)
Date
Last 7 days (174)
Last 30 days (712)
Last 365 days (10301)
2026 (945)
2025 (10504)
2024 (12823)
2023 (14649)
2022 (16550)
2021 (18148)
2020 (17278)
2019 (15440)
2018 (11906)
2017 (10792)
2016 (9613)
2015 (10701)
2014 (7662)
2013 (6211)
2012 (6484)
2011 (6760)
2010 (5443)
Location
Africa (355)
Alabama (39)
Alaska (7)
Arizona (57)
Arkansas (6)
Asia (14349)
Australia (2479)
California (3552)
Canada (964)
China (501)
Colorado (175)
Connecticut (177)
Delaware (130)
Europe (33462)
Florida (503)
Georgia (95)
Hawaii (3)
Idaho (26)
Illinois (297)
India (28)
Indiana (176)
Iowa (10)
Japan (189)
Kansas (29)
Kentucky (7)
Louisiana (9)
Maine (15)
Maryland (444)
Massachusetts (2462)
Michigan (69)
Minnesota (199)
Mississippi (2)
Missouri (48)
Montana (6)
Nebraska (8)
Nevada (30)
New Hampshire (48)
New Jersey (1016)
New Mexico (8)
New York (962)
North Carolina (509)
North Dakota (1)
Northern California (1729)
Ohio (107)
Oklahoma (10)
Oregon (10)
Pennsylvania (716)
Puerto Rico (4)
Rhode Island (39)
South America (447)
South Carolina (10)
Southern California (1366)
Tennessee (42)
Texas (536)
United States (12605)
Utah (115)
Virginia (76)
Washington D.C. (25)
Washington State (261)
West Virginia (2)
Wisconsin (33)
Wyoming (1)
204,529 Results for "i mab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments
September 9, 2025
·
8 min read
Press Releases
I-Mab to Participate in September 2025 Investor Conferences
August 21, 2025
·
1 min read
Layoffs
I-Mab Cuts 27% of Workforce After Pipeline Re-Prioritization
The layoffs follow an announcement in early January that I-Mab will re-prioritize resources to focus on advancing a CLDN18.2 and 4-1BB bispecific antibody for gastric cancers.
January 29, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Everest Medicines Expands Strategic Investment in I-MAB
August 4, 2025
·
6 min read
Press Releases
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
February 3, 2026
·
5 min read
Press Releases
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
October 17, 2025
·
15 min read
Press Releases
I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update
August 20, 2025
·
17 min read
Press Releases
I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
October 15, 2025
·
5 min read
Press Releases
I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares
August 4, 2025
·
5 min read
Press Releases
I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025
October 22, 2025
·
10 min read
1 of 20,453
Next
